Dexmeditomedine Versus No Sedation in Management of Agitation in COPD Patients Receiving Noninvasive Ventilation
Overview
The aim is to compare sedation using dexmedetomidine to sedation -free approach in management of agitated COPD patients receiving NIV
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Retrospective
- Study Primary Completion Date: December 2025
Detailed Description
The aim is to compare sedation using dexmedetomidine to sedation -free approach in management of agitated COPD patients receiving NIV
Clinical Trial Outcome Measures
Primary Measures
- precedex on COPD irritable on non invasive machine
- Time Frame: 3/2023_3/2025
- control of Agitation by RASS
Participating in This Clinical Trial
Inclusion critera
- age>18 – Agitation – NIV intolerance Exclusion criteria – cardiac dysfunction – Hepatic dysfunction – Haemodynamic instability
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: 100 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Assiut University
- Provider of Information About this Clinical Study
- Principal Investigator: Hoda sultan, Principle investigator – Assiut University
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.